MUMBAI: The Indian audience loves watching the talented sector of the country showcase it on the screen. That’s the reason why a reality show like India’s Got Talent has not just become popular but has even sustained for five seasons. Taking the concept forward, FremantleMedia India, the production house behind the show, has announced the launch of a unique initiative called CEO’s Got Talent.
CEOs, who form the backbone of Corporate India, will compete against each other to put their unique talents under the spotlight, that usually don’t come into play in their boardroom lives. A first-of-its-kind property created by FremantleMedia within the ‘Got Talent’ franchise, is an effort to recognise the creativity and talent amongst CEOs, which often remains hidden due to their intense day to day business-led lives.
The programme will feature 12 CEOs and will take place at the Grand Hyatt on Friday, 7 March, 2014. It will be broadcast on CNBC TV18 .
Produced by FremantleMedia and presented by Blackberry Messenger, the initiative will invite CEOs from India Inc. who will compete on this stage. The special event will have Raj Nayak, CEO – COLORS, as jury member among notable personalities. The most talented CEO will be chosen from among the 12 participating CEOs, who will showcase their lighter and talented side thereby making it a fun evening.
FremantleMedia India MD Anupama Mandloi said: “We are excited to launch this unique format, a first-of-its-kind adaptation of our global ‘Got Talent’ Franchise. With CNBC TV18 as our broadcast partner, our endeavour is to reach out to the core business leaders in the country and show-case their talent outside of the corporate board rooms!”
She further added, “The response has been fantastic and we look forward to some very enthusiastic participation.”
Proceeds from CEOs Got Talent will go to Genesis Foundation that provides financial support for life-saving and life-changing medical intervention for critically ill under-privileged children in areas of cancer, cardiac disorder, organ failure, thalassemia and extreme deformities.